Pages that link to "Q34192343"
Jump to navigation
Jump to search
The following pages link to Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse. (Q34192343):
Displaying 50 items.
- The calcium pump plasma membrane Ca(2 )-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin. (Q27317001) (← links)
- Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context. (Q30238959) (← links)
- The role of astrocytes in CNS tumors: pre-clinical models and novel imaging approaches (Q30618244) (← links)
- A machine learned classifier that uses gene expression data to accurately predict estrogen receptor status (Q30710027) (← links)
- PRMT2 and RORγ expression are associated with breast cancer survival outcomes (Q33632034) (← links)
- Breast cancer brain metastases: evidence for neuronal-like adaptation in a 'breast-to-brain' transition? (Q33738679) (← links)
- Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts (Q33742688) (← links)
- Novel therapeutic strategies in the treatment of triple-negative breast cancer (Q33887682) (← links)
- Approaches for optimal drug development and clinical trial design for breast cancer brain metastasis (Q33891408) (← links)
- Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer (Q33916814) (← links)
- Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients. (Q33917567) (← links)
- A computational model to predict bone metastasis in breast cancer by integrating the dysregulated pathways (Q34168896) (← links)
- Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancer. (Q34708283) (← links)
- Metastatic progression of breast cancer: insights from 50 years of autopsies. (Q34891023) (← links)
- Vascular endothelial growth factor C promotes breast cancer progression via a novel antioxidant mechanism that involves regulation of superoxide dismutase 3. (Q35000353) (← links)
- Luminal progenitor and fetal mammary stem cell expression features predict breast tumor response to neoadjuvant chemotherapy (Q35020412) (← links)
- Genomic analyses across six cancer types identify basal-like breast cancer as a unique molecular entity (Q35079683) (← links)
- Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey (Q35143022) (← links)
- Combining functional genomics strategies identifies modular heterogeneity of breast cancer intrinsic subtypes (Q35149532) (← links)
- Retrospective analysis of metastatic behaviour of breast cancer subtypes (Q35252752) (← links)
- Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA-Wild-Type Triple-Negative Breast Cancer (Q35374807) (← links)
- Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines. (Q35551911) (← links)
- Triple-Negative Breast Cancer: Clinical and Histological Correlations. (Q35576252) (← links)
- An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patients (Q35611844) (← links)
- Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients (Q35651216) (← links)
- Breaking and entering into the CNS: clues from solid tumor and nonmalignant models with relevance to hematopoietic malignancies (Q35786301) (← links)
- c-Jun N-terminal kinase 2 prevents luminal cell commitment in normal mammary glands and tumors by inhibiting p53/Notch1 and breast cancer gene 1 expression (Q35828457) (← links)
- Organ-specific adaptive signaling pathway activation in metastatic breast cancer cells (Q35828652) (← links)
- Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases (Q35889638) (← links)
- CIB1 depletion impairs cell survival and tumor growth in triple-negative breast cancer. (Q35892362) (← links)
- G Protein Coupled Receptor Kinase 3 Regulates Breast Cancer Migration, Invasion, and Metastasis (Q35980816) (← links)
- NSG Mice Provide a Better Spontaneous Model of Breast Cancer Metastasis than Athymic (Nude) Mice (Q36143238) (← links)
- Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple Metastases (Q36214193) (← links)
- A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis (Q36251962) (← links)
- Breast carcinoma subtypes show different patterns of metastatic behavior (Q36253544) (← links)
- P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients (Q36289931) (← links)
- Extensive quantitative remodeling of the proteome between normal colon tissue and adenocarcinoma. (Q36321648) (← links)
- Normal cell phenotypes of breast epithelial cells provide the foundation of a breast cancer taxonomy (Q36397832) (← links)
- Bridging cancer biology with the clinic: relative expression of a GRHL2-mediated gene-set pair predicts breast cancer metastasis. (Q36618503) (← links)
- Molecular characterization of basal-like and non-basal-like triple-negative breast cancer (Q36630430) (← links)
- FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies (Q36688951) (← links)
- EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low (Q36689065) (← links)
- A novel gene expression signature for bone metastasis in breast carcinomas (Q36761684) (← links)
- The Nuclear Receptor, RORγ, Regulates Pathways Necessary for Breast Cancer Metastasis (Q36869918) (← links)
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer (Q36908403) (← links)
- Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways. (Q36924443) (← links)
- Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain. (Q36924473) (← links)
- Multi-disciplinary management for patients with oligometastases to the brain: results of a 5 year cohort study (Q36985780) (← links)
- Practical implications of gene-expression-based assays for breast oncologists. (Q36989546) (← links)
- Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancers. (Q37120418) (← links)